Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 1/2 2Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Turcot syndrome 1Triple Negative Breast Neoplasms 1Thyroid Carcinoma, Anaplastic 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Muscle Invasive Bladder Urothelial Carcinoma 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Squamous Cell Carcinoma 1Epithelial Ovarian 1EGFR Positive Non-small Cell Lung Cancer 1Colorectal Neoplasms, Hereditary Nonpolyposis 1

Interventions

alpha-Synuclein 2Cyclophosphamide 2temsirolimus 1fludarabine 1Valproic Acid 1Resistant Starch 1Paclitaxel 1Interleukin-2 1Indocyanine Green 1Carboxylesterase 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Solid Tumor × Paclitaxel × Clear all
NCT04046016 2019-08-06

A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor

Seoul National University Hospital

Phase EARLY_PHASE1 Completed
2 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡